Concepedia

Bernardo Goulart

BG

Statistics

Publications

7

Citations

710

H-Index

7

Active since

2008

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

University of Washington Medical Center

Bernardo Goulart is an author at Fred Hutch Cancer Center specializing in oncology, medicine, and metastasis.

Publications per year

2008–2019

7

Publications

7

Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation

Laurie L. Carr, David A. Mankoff, Bernardo Goulart et al. · Clinical Cancer Research · 2010 · 418 citations · Full text

, , +17

A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer

Cristina P. Rodriguez, Qian Wu, Jenna Voutsinas et al. · Clinical Cancer Research · 2019 · 175 citations

, , +13

Phase II study of sunitinib in iodine refractory, well-differentiated thyroid cancer (WDTC) and metastatic medullary thyroid carcinoma (MTC)

Bernardo Goulart, Laurie Carr, R. G. Martins et al. · Journal of Clinical Oncology · 2008 · 32 citations

, , +17

Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis

Bernardo Goulart, Jeffrey W. Clark, Gregory Y. Lauwers et al. · Journal of Hematology & Oncology · 2009 · 26 citations · Full text

, , +14

Phase II trial of continuous dosing of sunitinib in advanced, FDG-PET avid, medullary thyroid carcinoma (MTC) and well-differentiated thyroid cancer (WDTC)

Laurie Carr, Bernardo Goulart, Renato Martins et al. · Journal of Clinical Oncology · 2009 · 21 citations

, , +16

1–5 of 7